| Product Name | MF | CAS | Details |
|---|
| Upadacitinib-15N-d2 | Details |
| Bisoprolol | C18H31NO4 | 66722-44-9 | Details |
| Norepinephrine Impurity 85 HCl | Details |
| Bumetanide Impurity 80 | Details |
| DL-2-Aminoheptanedioic acid | C7H13NO4 | 627-76-9 | Details |
| N-Cbz-L-isoleucine | C14H19NO4 | 3160-59-6 | Details |
| Cannabichromene | C21H30O2 | 20675-51-8 | Details |
| Halometasone Impurity N1 | C20H23ClF2O3 | 136132-00-8 | Details |
| Halometasone Impurity N2 | C21H25ClF2O5 | 80157-55-7 | Details |
| Cabe Palace Suya Inkstone II TFA | Details |
| Cabe Palace Suya Inkstone I TFA | Details |
| Alendronic Acid Impurity 7 | Details |
| Mianserin impurity 42 | Details |
| 1,2-Dioctanoylglycerol | C19H36O5 | 1069-87-0 | Details |
| Cefaclor Impurity 23 | C13H13N3O6S | 1426173-90-1 | Details |
| Perindoprilat-d4 | C17H28N2O5 | 1356841-18-3 | Details |
| 2-Amino-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide (Clonazepam Impurity) | C15H12ClN3O4 | 17714-02-2 | Details |
| Ciclesonide 22S-Epimer | C32H44O7 | 141845-81-0 | Details |
| Labetalol Impurity 31 | Details |
| Ivabradine Impurity 7 | C16H24N2O3 | 85175-77-5 | Details |
| Trimebutine EP Impurity D | C22H29NO5 | 92414-09-0 | Details |
| Epinastine Impurity 30 | C23H21N3OS | Details |
| Dinoprost trometamol | C24H45NO8 | 38562-01-5 | Details |
| Methotrexate Impurity 17 HBr | C7H8Br2N6 | 52853-40-4 | Details |
| Empagliflozin Impurity 97 | C13H10ClIO | 1459754-32-5 | Details |
| Epinastine Impurity 28 | C8H5NOS | 532-55-8 | Details |
| Prilocaine Impurity 8 DiHCl | C8H12N2 | 13438-26-1 | Details |
| Benzyl-d7 Alcohol | C7HD7O | 71258-23-6 | Details |
| H-4-Chloro-Phe-OH | C9H10ClNO2 | 14173-39-8 | Details |
| Isopropyl 2-(4-Isobutylphenyl)Propanoate | C16H24O2 | 64622-17-9 | Details |
| Cefaclor Oxide Impurity | Details |
| Sodium glycollate | C2H3NaO3 | 2836-32-0 | Details |
| Rocuronium Impurity 17 | C19H28O | 963-75-7 | Details |
| Lumateperone Impurity 17 HCl | Details |
| Mepivacaine EP Impurity D HCl | Details |
| Linezolid Impurity 94 | Details |
| Etomidate Impurity 8 | C12H17NO2 | 66512-37-6 | Details |
| Tiopronin Impurity 4 | C3H6O2S | 79-42-5 | Details |
| Linezolid Impurity86 HCl | C15H22FN3O3 | 333753-69-8 | Details |
| Avanafil Impurity 101 | C5H11NO | 770697-08-0 | Details |
| Epinastine Impurity 44 Fumarate | C19H20N2O4 | 127785-96-0 | Details |
| Cisatracurium Besilate EP Impurity O | C6H5O3S- | Details |
| Lurasidone Impurity 20 | C31H38N6O2S2 | Details |
| Lurasidone Impurity 19 | C8H14Cl2 | 61169-66-2 | Details |
| Bicalutamide Impurity 13 | C12H9F3N2O | 90357-53-2 | Details |
| Argatroban Impurity 33 | C15H29ClN6O5 | 74874-08-1 | Details |
| Oxoadipicacid | C6H8O5 | 3184-35-8 | Details |
| Phosphoric acid methyl ester | CH4O.xH3O4P | 12789-45-6 | Details |
| Arachidic Acid | C20H40O2 | 506-30-9 | Details |
| 2-Sulfamoylbenzoic acid | C7H7NO4S | 632-24-6 | Details |
| D-Methionine | C5H11NO2S | 348-67-4 | Details |
| Withanoside IV | C40H62O15 | 362472-81-9 | Details |
| Fulvic acid | C14H12O8 | 479-66-3 | Details |
| Empagliflozin impurity 02 | Details |
| Methotrexate impurity N3 | C22H26N8O5 | 65148-64-3 | Details |
| (-)-Globulol(sum of enantiomers) | C15H26O | 489-41-8 | Details |
| 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine | C6H7F3N4 | 486460-21-3 | Details |
| 24703-35-3 Bicyclo(8.1.0)undeca-2,6-diene, 3,7,11,11-tetramethyl-, (1S-(1R*,2E,6E,10S*))- Bicyclogermacrene (+)-Bicyclogermacrene Bicyclogermacren | C15H24 | 24703-35-3 | Details |
| α-Gurjunene | C15H24 | 489-40-7 | Details |
| Trimethylhexamethylene Diisocyanate (2,2,4- and 2,4,4- mixture) | C11H18N2O2 | 28679-16-5 | Details |
| 2,4-Dihydroxybenzaldehyde | C7H6O3 | 95-01-2 | Details |
| Propyl Bromoacetate | C5H9BrO2 | 35223-80-4 | Details |
| Propan-2-ylidenehydrazine | C3H8N2 | 5281-20-9 | Details |
| Progesterone Impurity N2 | C22H34O2 | 40736-33-2 | Details |
| Potassium 2-mercaptoacetate | C2H3KO2S | 34452-51-2 | Details |
| N-Phenyl-N'-(2-methylphenyl)-p-phenylenediamine | C19H18N2 | 27173-16-6 | Details |
| Lauroscholtzine | C20H23NO4 | 2169-44-0 | Details |
| n-Hentetracontane | C41H84 | 7194-87-8 | Details |
| Nafamostat Impurity 15 | C7H5NO3 | 619-68-1 | Details |
| Nafamostat | C19H17N5O2 | 81525-10-2 | Details |
| N-(1-(5,6-Dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride | C22H25ClF3N | 2514708-62-2 | Details |
| Methyl 4-methyl-3-oxotetrahydrothiophene-2-carboxylate | C7H10O3S | 2689-70-5 | Details |
| Methyl 3-((2-methoxy-2-oxoethyl)thio)-2-methylpropanoate | C8H14O4S | 38293-65-1 | Details |
| Lipase AY 30 | C11H9N3NaO2+ | 9001-62-1 | Details |
| Galegine | C6H13N3 | 543-83-9 | Details |
| Fospropofol Disodium Salt | C13H19O5P.2Na | 258516-87-9 | Details |
| Dihydro Vitamin K1 | C31H48O2 | 572-96-3 | Details |
| Propionyl Bromide | C3H5BrO | 598-22-1 | Details |
| Difenzoquat | C17H17N2+ | 49866-87-7 | Details |
| Diethyl 2-(6-bromohexyl)malonate | C13H23BrO4 | 6557-85-3 | Details |
| Crizotinib Impurity 01 | C26H30Cl2FN5O3 | 877399-51-4 | Details |
| Clenbuterol EP Impurity B | C12H16Cl2N2O | 69708-36-7 | Details |
| Bis(2-chloroethyl)amine | C4H9Cl2N | 334-22-5 | Details |
| Betamethasone benzoate | C35H41FO8 | 22298-29-9 | Details |
| Adapalene Impurity 3 | C17H22O | 726-94-3 | Details |
| 5-Nitro-2-Benzimidazolinone | C7H5N3O3 | 93-84-5 | Details |
| 4-O-Feruloylquinic acid | C17H20O9 | 2613-86-7 | Details |
| 2-Oxo-2-(piperidin-1-yl)acetic acid | C7H11NO3 | 4706-33-6 | Details |
| 2-Hydroxy-4-n-hexyloxybenzophenone | C19H22O3 | 3293-97-8 | Details |
| Baloxavir impurity C94 | C27H24FN3O7S | 1985606-40-3 | Details |
| Butyl 2-bromoacetate | C6H11BrO2 | 18991-98-5 | Details |
| 2-[4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(n-octyloxy)phenol | C33H39N3O2 | 2725-22-6 | Details |
| 2,6-Di-sec-butylphenol | C14H22O | 5510-99-6 | Details |
| 2,3,5-Trichloro-1,4-benzoquinone | C6HCl3O2 | 634-85-5 | Details |
| 2-(3-((4-Amino-2-methylpyrimidin-5-yl)methyl)-4-methylthiazol-3-ium-5-yl)ethyl hydrogen phosphate | C12H17N4O4PS | 495-23-8 | Details |
| 2-((1R,3S,4S)-4-Methyl-3-(prop-1-en-2-yl)-4-vinylcyclohexyl)propan-2-ol | C15H26O | 639-99-6 | Details |
| (6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahexaenoic Acid | C24H36O2 | 68378-49-4 | Details |
| Acalabrutinib Impurity 5 | C22H21N7O | 1420478-90-5 | Details |
| Acalabrutinib Impurity 4 | C26H23N7O2 | 1952316-43-6 | Details |
| Product Total： Product Page： | ||||
| 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 | ||||